- Home
- ESPR vs COE Comparison
ESPR vs COE Comparison
Compare ESPR & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- COE
- Stock Information
- Founded
- ESPR 2008
- COE 2011
- Country
- ESPR United States
- COE Singapore
- Employees
- ESPR N/A
- COE N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- COE Other Consumer Services
- Sector
- ESPR Health Care
- COE Real Estate
- Exchange
- ESPR Nasdaq
- COE Nasdaq
- Market Cap
- ESPR 220.0M
- COE 177.0M
- IPO Year
- ESPR 2013
- COE 2016
- Fundamental
- Price
- ESPR $1.40
- COE $30.40
- Analyst Decision
- ESPR Buy
- COE
- Analyst Count
- ESPR 6
- COE 0
- Target Price
- ESPR $6.50
- COE N/A
- AVG Volume (30 Days)
- ESPR 5.1M
- COE 11.3K
- Earning Date
- ESPR 08-05-2025
- COE 08-22-2025
- Dividend Yield
- ESPR N/A
- COE N/A
- EPS Growth
- ESPR N/A
- COE N/A
- EPS
- ESPR N/A
- COE N/A
- Revenue
- ESPR $259,574,000.00
- COE $59,490,000.00
- Revenue This Year
- ESPR $6.10
- COE N/A
- Revenue Next Year
- ESPR N/A
- COE N/A
- P/E Ratio
- ESPR N/A
- COE N/A
- Revenue Growth
- ESPR 12.99
- COE 91.87
- 52 Week Low
- ESPR $0.69
- COE $11.84
- 52 Week High
- ESPR $3.94
- COE $34.74
- Technical
- Relative Strength Index (RSI)
- ESPR 58.85
- COE 59.96
- Support Level
- ESPR $1.13
- COE $28.50
- Resistance Level
- ESPR $1.74
- COE $29.38
- Average True Range (ATR)
- ESPR 0.17
- COE 1.01
- MACD
- ESPR 0.01
- COE -0.13
- Stochastic Oscillator
- ESPR 30.61
- COE 42.83
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.